Abstract: Objective To evaluate the efficacy and safety of Evolocumab for lowering low density lipoprotein cholesterol (LDL-C ). Methods Electronic databases were searched to identify all randomized controlled trials comparing Evolocumab and palcebo for hypercholes

Key words: cardiovascular diseases, cholesterol;LDL, evolocumab, subtilisins, meta-analysis